Current Understanding of Optimal Prevention of Helicobacter pylori-Induced Cancer
- PMID: 40348495
- PMCID: PMC12232452
- DOI: 10.1016/j.gtc.2024.12.005
Current Understanding of Optimal Prevention of Helicobacter pylori-Induced Cancer
Abstract
Gastric cancer is the fifth most common cancer and the fifth most common cause of cancer-related death globally. The key to improving outcomes lies in effective prevention and early detection, which are critical for successful curative interventions. Helicobacter pylori is the strongest known risk factor for gastric cancer, and eradication of this pathogen is critical for reducing cancer risk. By synthesizing current evidence and exploring the advanced therapeutic approaches, this review provides a comprehensive overview of best practices for mitigating gastric cancer through targeted bacterial intervention.
Keywords: Chemoprevention; Gastric cancer; Helicobacter pylori.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have no potential conflicts (financial, professional, or personal) that are relevant to this article.
Figures
References
-
- Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74(3):229–63. - PubMed
-
- Bergquist JR, Leiting JL, Habermann EB, et al. Early-onset gastric cancer is a distinct disease with worrisome trends and oncogenic features. Surgery 2019;166(4):547–55. - PubMed
-
- Sung H, Jiang C, Bandi P, et al. Differences in cancer rates among adults born between 1920 and 1990 in the USA: an analysis of population-based cancer registry data. Lancet Public Health 2024;9(8):e583–93. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
